Physician profile
Tracy Wimbush
NPI 1780669739
$854.87
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $386 · 2020: $17.36 · 2022: $49.82 · 2023: $256 · 2024: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $401.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $270.83 | 2022-2023 | Proclaim, Eterna |
| Nevro Corp. | $201.47 | 2019-2024 | Senza |
| Biodelivery Sciences International, INC. | $100.10 | 2019 | |
| Zyla Life Sciences, INC. | $75.05 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $56.72 | 2019 | |
| Kaleo, INC. | $52.66 | 2019 | |
| Boston Scientific Corporation | $27.04 | 2019 | |
| Novo Nordisk INC | $20.46 | 2023 | Wegovy |
| Allergan, INC. | $18.50 | 2019 | |
| Mdd US Operations, LLC | $17.99 | 2019 | |
| Spr Therapeutics, INC | $14.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Wimbush listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.